Morphophenotypic Classification of Hepatocellular Carcinoma: the Biliary/Stem Cell Subgroup and Worst Outcome—Implications on Patient Selection
Authors:
- 14 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 25 (3) , 698-707
Abstract
No abstract availableKeywords
Funding Information
- APEF (Bolsa de Investigação em Carcinoma Hepatocelular APEF/Bayer 2019)
This publication has 50 references indexed in Scilit:
- Hepatocellular Carcinomas Expressing ‘Stemness'-Related Markers: Clinicopathological CharacteristicsDigestive Diseases, 2014
- Prognostic Value of Microvessel Density in Hepatocellular Carcinoma Patients: A Meta-AnalysisThe International Journal of Biological Markers, 2014
- Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinomaHistopathology, 2014
- Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinomaWorld Journal of Gastroenterology, 2014
- Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studiesLiver International, 2009
- Liver biopsy†Hepatology, 2009
- Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysisGut, 2008
- Clinicopathologic Features of Hepatocellular Carcinoma Patients with Compensated Cirrhosis Surviving More than 10 Years after Curative HepatectomyWorld Journal of Surgery, 2007
- A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cellsNature Medicine, 2006
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999